Načítá se...
Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Canavan disease (CD) is a fatal leukodystrophy caused by mutation of the aspartoacylase (ASPA) gene, which leads to deficiency in ASPA activity, accumulation of the substrate N‐acetyl‐L‐aspartate (NAA), demyelination, and spongy degeneration of the brain. There is neither a cure nor a standard treat...
Uloženo v:
| Vydáno v: | Adv Sci (Weinh) |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709977/ https://ncbi.nlm.nih.gov/pubmed/33304759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002155 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|